The Food and Drug Administration’s rare pediatric disease priority review voucher program, which has been providing incentives for lifesaving innovations since 2012, is doomed to disappear unless ...
Alexander was a Senior Research Associate for the Center for Data Analysis at The Heritage Foundation. In 2023 alone, there were around 450,000 approved H-1B applications. The majority of these were ...